Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026)

Alkermes (ALKS) reported Other Accumulated Expenses of $136.8 million for Q1 2026, up 64.63% year-over-year from $83.1 million in Q1 2025, and up 37.94% quarter-over-quarter from $99.2 million in Q4 2025.

Alkermes (ALKS) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Other Accumulated Expenses data on file, last reported at $136.8 million in Q1 2026.

  • Other Accumulated Expenses for Q1 2026 came in at $136.8 million, up 64.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $136.8 million (up 64.63% YoY), and the FY2025 annual result was $99.2 million, up 44.26% from the prior year.
  • Other Accumulated Expenses improved to $136.8 million in Q1 2026 per ALKS's latest filing, from $99.2 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $136.8 million in Q1 2026 and troughed at $67.3 million in Q3 2024.
  • A 5-year average of $93.3 million and a median of $91.0 million in 2022 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2026: Other Accumulated Expenses dropped 25.12% in 2024, then soared 64.63% in 2026.
  • A 5-year view of Other Accumulated Expenses shows it stood at $108.2 million in 2022, then declined by 15.12% to $91.8 million in 2023, then retreated by 25.12% to $68.7 million in 2024, then surged by 44.26% to $99.2 million in 2025, then jumped by 37.94% to $136.8 million in 2026.
  • Business Quant data shows ALKS's Other Accumulated Expenses at $136.8 million in Q1 2026, $99.2 million in Q4 2025, and $79.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 136.79 Mn
Dec 31, 2025 99.17 Mn
Sep 30, 2025 79.79 Mn
Jun 30, 2025 90.00 Mn
Mar 31, 2025 83.09 Mn
Dec 31, 2024 68.74 Mn
Sep 30, 2024 67.26 Mn
Jun 30, 2024 85.64 Mn
Mar 31, 2024 81.59 Mn
Dec 31, 2023 91.81 Mn
Sep 30, 2023 88.45 Mn
Jun 30, 2023 98.35 Mn
Mar 31, 2023 105.30 Mn
Dec 31, 2022 108.16 Mn
Sep 30, 2022 117.06 Mn
Jun 30, 2022 93.90 Mn
Mar 31, 2022 91.02 Mn
Dec 31, 2021 75.51 Mn
Sep 30, 2021 101.44 Mn
Jun 30, 2021 68.05 Mn